Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells
Prostate cancer (PCa) is the second most common malignancy and is the fifth leading cause of cancer mortality among men globally. Docetaxel-based therapy remains the first-line treatment for metastatic castration-resistant prostate cancer. However, dose-limiting toxicity including neutropenia, myelo...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/34234/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|